Search results for "acids"

showing 10 items of 3520 documents

Novel concepts on the recovery of by-products from alkaline pulping

2016

Innovative biorefinery concepts were developed for the separation and utilization of organic materials, especially aliphatic carboxylic acids, lignin, and extractives, which are formed as by-products during wood-based alkaline delignification processes. The partial recovery of sodium as NaOH and aliphatic carboxylic acids from hardwood soda-AQ black liquor was studied via electrodialysis. The lignin was partly (about 59 % of the initial lignin) precipitated from black liquor by carbonation (pH to about 8.5) followed by electrodialysis or H2SO4 (pH to about 2), with subsequent precipitation of more lignin and the liberation of aliphatic acids. The Na2SO4 formed was successfully separated fro…

carbonationesteritkarboksyylihapotmäntyöljyaliphatic carboxylic acidsrasvahapotfood and beveragesligninselluligniiniblack liquormustalipeätall oil fatty acidscomplex mixturesalifaattiset yhdisteetacidificationestersglucoisosaccharinic acidtalteenottoselluteollisuussivutuotteetnatriumelektrodialyysielectrodialysishappokäsittely
researchProduct

Influence of Anion and Cation Structure of Ionic Liquids on Carboxylic Acids Extraction

2019

A recently proposed new mechanism and a model of reactive extraction of carboxylic acids by hydrophobic ionic liquids (ILs) was tested on five systems from published as well as from new equilibrium data on liquid-liquid extraction of butyric and lactic acids (BA and LA) from aqueous solutions. Two phosphonium and one ammonium ILs were used. The model describes experimental data for all systems with a good fit. The mechanism of acid extraction by ILs is very similar for all tested systems. This indicates a more general validity of the developed model. The model allows deeper understanding of regularities in carboxylic acid extraction by hydrophobic ILs. Stability constants of the first acid-…

carboxylic acidsL/L equilibriumCarboxylic acid02 engineering and technologyPhosphinate010402 general chemistry01 natural sciencesHydrophobic effectlcsh:Chemistryionic liquidschemistry.chemical_compoundPolymer chemistryPhosphoniumOriginal Researchchemistry.chemical_classificationAqueous solutionmodelGeneral Chemistry021001 nanoscience & nanotechnologyinfluence of structure0104 chemical sciencesSolventChemistrychemistrylcsh:QD1-999Stability constants of complexesIonic liquidextraction0210 nano-technologyFrontiers in Chemistry
researchProduct

Electrochemical oxidation of carboxylic acids at boron doped diamonds

2010

carboxylic acidselectrochemical incinerationSettore ING-IND/27 - Chimica Industriale E Tecnologicawastewaterchronoamperometric measurement
researchProduct

Bringing a Molecular Plus One : Synergistic Binding Creates Guest-Mediated Three-Component Complexes

2020

C-Ethyl-2-Methylresorcinarene (A), pyridine (B), and a set of ten carboxylic acids (Cn) associate to form A·B·Cn ternary assemblies with 1:1:1 stoichiometry, representing a useful class of ternary systems where the guest mediates complex formation between the host and a third component. Although individually weak in solution, the combined strength of the multiple non-covalent interactions organizes the complexes even in a highly hydrogen-bond competing methanol solution as explored by both experimental and computational methods. The interactions be-tween A·B and Cn are dependent on the pKa values of carboxylic acids. The weak interactions between A and C further reinforce the interactions b…

carboxylic acidskarboksyylihapotsupramolekulaarinen kemiamolekyylitmolecular recognitionsupramolecular chemistrydiagnostic toolstunnistaminen
researchProduct

Dynamic Stabilization of the Ligand-Metal Interface in Atomically Precise Gold Nanoclusters Au68 and Au144 Protected by meta-Mercaptobenzoic Acid

2017

Ligand-stabilized, atomically precise gold nanoclusters with a metal core of a uniform size of just 1–3 nm constitute an interesting class of nanomaterials with versatile possibilities for applications due to their size-dependent properties and modifiable ligand layers. The key to extending the usability of the clusters in applications is to understand the chemical bonding in the ligand layer as a function of cluster size and ligand structure. Previously, it has been shown that monodispersed gold nanoclusters, stabilized by meta-mercaptobenzoic acid (m-MBA or 3-MBA) ligands and with sizes of 68–144 gold atoms, show ambient stability. Here we show that a combination of nuclear magnetic reson…

carboxylic acidsspectroscopyGeneral Physics and AstronomyInfrared spectroscopyNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesNanoclustersNanomaterialsMetalMolecular dynamicsNMR spectroscopyGeneral Materials Scienceclustersta116thiolsta114LigandChemistryGeneral Engineeringgold021001 nanoscience & nanotechnologymolecular dynamicsvibrational spectroscopy0104 chemical sciencesCrystallographyChemical bondgold nanoclustervisual_artvisual_art.visual_art_mediumDensity functional theory0210 nano-technologyACS Nano
researchProduct

Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet

2015

Background: the ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD’s positive effects on metabolism and cardiovascular risk factors are similar to those seen after n-3 polyunsaturated fatty acids (ω-3) supplementation. We hypothesized that a ketogenic Mediterranean diet with phytoextracts combined with ω-3 supplementation may have increased positive effects on cardiovascular risk factors and inflammation. Methods: We analyzed 34 male overweight subjects

cardiovascular risk factorsBlood GlucoseMaleMediterranean dietinflammatory cytokinesmedicine.medical_treatmentN-3 polyunsaturated fatty acidPharmaceutical ScienceOverweightDiet Mediterraneanchemistry.chemical_compoundRisk FactorsWeight lossDrug DiscoveryInsulinlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Adipositychemistry.chemical_classificationCardiovascular risk factors; Inflammatory cytokines; Ketogenic diet; N-3 polyunsaturated fatty acids; Omega-3; Weight loss; Drug Discovery3003 Pharmaceutical ScienceMiddle Agedn-3 polyunsaturated fatty acidsketogenic dietCardiovascular DiseasesCytokinesomega-3medicine.symptomDiet KetogenicPolyunsaturated fatty acidAdultmedicine.medical_specialtyInflammatory cytokineBiologyCardiovascular risk factorWeight loArticleInternal medicineFatty Acids Omega-3Weight LossmedicineHumansTriglyceridesAgedAdiponectinPlant ExtractsCholesterolDrug Discovery3003 Pharmaceutical Science<i>n</i>-3 polyunsaturated fatty acidsCholesterol LDLOverweightEndocrinologylcsh:Biology (General)chemistryDietary SupplementsUric acidKetogenic dietMarine Drugs
researchProduct

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia.

2010

Ezetimibe is a selective cholesterol absorption inhibitor with an excellent side-effect profile, able to reduce low-density lipoprotein (LDL) cholesterol by 15-25% from baseline in monotherapy and on top of statins and fibrates. Yet, it seems that ezetimibe produces quantitative rather than qualitative changes in LDL, with small net effects on atherogenic dyslipidaemia. This is supported by findings from the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) study on atherosclerosis progression, where the addition of ezetimibe to simvastatin in patients with heterozygous familial hypercholesterolaemia did not affect the mean change in carotid int…

cardiovascular riskAortic valvemedicine.medical_specialtydyslipidaemiamedicine.drug_classezetimibe cardiovascular risk atherosclerosis dyslipidaemiachemistry.chemical_compoundEzetimibeInternal medicineClinical endpointMedicineCholesterol absorption inhibitorcardiovascular diseasesReview Paperbusiness.industryCholesterolnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseStenosismedicine.anatomical_structureEndocrinologychemistrySimvastatinCardiologylipids (amino acids peptides and proteins)atherosclerosisbusinessezetimibeLipoproteinmedicine.drug
researchProduct

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes

2022

The current management of Type 2 Diabetes Mellitus (T2DM) includes incretin-based treatments able to enhance insulin secretion and peripheral insulin sensitivity as well as improve body mass, inflammation, plasma lipids, blood pressure, and cardiovascular outcomes. Dietary Free Fatty Acids (FFA) regulate metabolic and anti-inflammatory processes through their action on incretins. Selective synthetic ligands for FFA1-4 receptors have been developed as potential treatments for T2DM. To comprehensively review the available evidence for the potential role of FFA receptor agonists in the treatment of T2DM, we performed an electronic database search assessing the association between FFAs, T2DM, i…

cardiovascular riskMedicine (General)Cardiovascular risk Free fatty acidsGLP-1 Incretins Metabolism Type 2 diabetes Fatty Acids Nonesterified Humans Diabetes Mellitus Type 2 Insulin Resistanceendocrine system diseasesfree fatty acidsType 2 diabetesReviewGeneral MedicineFatty Acids NonesterifiedR5-920Diabetes Mellitus Type 2HumansInsulin ResistanceGLP-1metabolismincretinsMedicina
researchProduct

Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.

2007

Increasing evidence suggests that the quality-rather than just the quantity-of low-density lipoproteins (LDLs) exerts a great influence on cardiovascular risk. LDLs comprise multiple subclasses with discrete size and density, and different physicochemical composition, metabolic behaviors, and atherogenicity. Individuals generally cluster into 2 broad subgroups. Most have a predominance of large LDLs, and some have a higher proportion of small particles. Small, dense LDLs are good predictors of cardiovascular events and progression of coronary artery disease. Their predominance has been accepted as an emerging cardiovascular risk factor by the National Cholesterol Education Program Adult Tre…

cardiovascular riskRiskStatinmedicine.drug_classHypercholesterolemiasubclassePharmacologyBioinformaticschemistry.chemical_compoundClofibric AcidEzetimibemedicineHumansPharmacology (medical)Cholesterol absorption inhibitorRosuvastatinRisk factorRosuvastatin CalciumNational Cholesterol Education ProgramSulfonamidessmall dense LDLfibrateCholesterolbusiness.industryAnticholesteremic AgentsstatinGeneral MedicineCholesterol LDLEzetimibeFluorobenzenesRosuvastatin CalciumPyrimidineschemistrydiabeteCardiovascular DiseasesAzetidineslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusinessrosuvastatinmedicine.drugAdvances in therapy
researchProduct

Treatment options for managing atherogenic dyslipidemia and fatty liver disease

2014

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries with up to 30% of the population affected. Since NAFLD is associated with an increased risk of cardiovascular (CV) disease, these patients should be stratified for CV risk factors, including atherogenic dyslipidemia, and managed accordingly. Lifestyle modifications represent an effective treatment for NAFLD, since most patients are overweight or obese. Also, promising, but not conclusive, results are available for current pharmacologic treatment. Drugs potentially effective against NAFLD include insulin sensitisers as well as fibrates and omega-3 polyunsaturated fatty acids, whil…

cardiovascular riskmedicine.medical_specialtymedicine.medical_treatmentPopulationcardiovascular risk dyslipidemia non-alcoholic fatty liver disease therapyDiseaseOverweightdyslipidemia fatty liver disease treatmentChronic liver diseaseBioinformaticsInternal medicineFatty Acids Omega-3medicineHumansPharmacology (medical)educationDyslipidemiaschemistry.chemical_classificationPharmacologyeducation.field_of_studytherapybusiness.industryInsulinMedicine (all)Fatty liverdyslipidemiaFibric Acidsnutritional and metabolic diseasesnon-alcoholic fatty liver diseaseGeneral Medicinemedicine.diseaseAtherosclerosisEndocrinologychemistrymedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessDyslipidemiaPolyunsaturated fatty acid
researchProduct